Biomedical Technology

InvivoGen Limited

🌍 Official Website 🏢 HKSTP Source
58 Potential

Decision Maker

Dr. Xiaobing LI
x.li@invivogen.com
+852 3622 3480
Unit 307, 3/F, Building 8W, No. 8 Science Park West Avenue, Hong Kong Science Park, Pak Shek Kok, Hong Kong
Raw Description
Product | Innovation within Reach | InvivoGen has been involved in handling microbes to produce a wide range of biological molecules for over forty years. In 1970s, Dr. Gérard Tiraby, the founder of InvivoGen and the professor of microbiology at the Université Toulouse III, discovered a unique antibiotic and named it Zeocin®; an anti-mycoplasma antibiotic, Plasmocin®, was also developed in the early 1980s and has been widely used by researchers to prevent or remove mycoplasma contamination in cell culture. In 1997, there was a ground breakthrough in the research of innate immune sensors. Thanks to our unique knowledge in microbiology, InvivoGen was the first to commercialize Toll-Like Receptors (TLRs) ligands in 2000 and has become the supplier with the most comprehensive range of products for innate immunology research. | As innate immunity expands to interdisciplinary field of study. InvivoGen therefore keeps enlarging our library of products and services for different research fields such as cancer immunotherapy, gene therapy, cell therapy, vaccine development and bioactivity screening for artificial intelligence drug discovery, etc. | | InvivoGen’s Life Science Research Products | Tools for detection and elimination of microbial contaminants | Selective antibiotics | Pattern recognition receptors (PRR) agonists and antagonist | Genes and proteins related to immunology | Reporter cell lines | Immune checkpoint antibodies | Vaccine adjuvants | COVID-19-related products | Technology | Innovation within Reach | InvivoGen has been involved in handling microbes to produce a wide range of biological molecules for over forty years. In 1970s, Dr. Gérard Tiraby, the founder of InvivoGen and the professor of microbiology at the Université Toulouse III, discovered a unique antibiotic and named it Zeocin®; an anti-mycoplasma antibiotic, Plasmocin®, was also developed in the early 1980s and has been widely used by researchers to prevent or remove mycoplasma contamination in cell culture. In 1997, there was a ground breakthrough in the research of innate immune sensors. Thanks to our unique knowledge in microbiology, InvivoGen was the first to commercialize Toll-Like Receptors (TLRs) ligands in 2000 and has become the supplier with the most comprehensive range of products for innate immunology research. | As innate immunity expands to interdisciplinary field of study. InvivoGen therefore keeps enlarging our library of products and services for different research fields such as cancer immunotherapy, gene therapy, cell therapy, vaccine development and bioactivity screening for artificial intelligence drug discovery, etc. | | InvivoGen’s Life Science Research Products | Tools for detection and elimination of microbial contaminants | Selective antibiotics | Pattern recognition receptors (PRR) agonists and antagonist | Genes and proteins related to immunology | Reporter cell lines | Immune checkpoint antibodies | Vaccine adjuvants | COVID-19-related products || InvivoGen was established in 1977, the first biotechnology company in France. We are serving life scientists worldwide with innovative and high-quality research reagents. Specializing in innate immunity, InvivoGen scientists foster the design and development of new tools and services to keep the pace with scientific breakthroughs. The leading active pipelines of InvivoGen facilitate cutting-edge and translational research.\u2028\u2028 | InvivoGen Limited was incorporated in the Hong Kong Science and Technology Park (HKSTP) in 2014. We aim at developing business opportunities and providing professional support to life science researchers in Asian-Pacific region.

Strategic Analysis

Executive Brief

InvivoGen is a global leader in innate immunity and microbiology, specializing in the development of culture-validated reagents, reporter cell lines, and tools for immunotherapy and vaccine research. Operating out of France and the Hong Kong Science and Technology Park (HKSTP), they focus on the intersection of microbial biology and drug discovery, including high-throughput screening and AI-driven drug development.

Strategic Fit & Lead Score

Lead Score: 58 (General Research / Engineering)

Why this Score? InvivoGen is primarily a biological reagent and cell-line company, not a semiconductor or heavy industrial firm. However, their transition into AI-driven drug discovery and high-throughput bioactivity screening creates a critical opening for 6C. The technical bottleneck in their field is shifting from "biology" to "sensing and data processing." 6C’s Boron Doped Diamond (BDD) for electrochemical sensing and PCD for thermal management in AI hardware represent high-value infrastructure upgrades for their R&D pipelines.

6C Solutions Proposal

Application Area 6C Solution Technical Value Prop
Electrochemical Biosensing BDD Electrodes Boron Doped Diamond offers the widest potential window in aqueous solutions and extreme resistance to fouling. Ideal for real-time monitoring of metabolites or cytokines in complex cell culture media without electrode degradation.
Microfluidics & Lab-on-Chip Diamond Coating (SCD/PCD) Direct diamond coating on microfluidic channels provides an ultra-low friction, chemically inert, and biocompatible surface. This prevents protein adsorption and "sticking" in high-precision cell therapy screening.
AI Drug Discovery Infrastructure PCD Heat Spreaders InvivoGen’s AI-driven drug discovery requires high-density GPU/ASIC clusters. 6C’s PCD heat spreaders (Thermal conductivity > 1800 W/mK) enable higher clock speeds and prevent thermal throttling in their discovery engines.
Contamination Control BDD Water Treatment For their "detection and elimination of microbial contaminants" division: BDD electrodes generate hydroxyl radicals (·OH) and ozone in-situ, providing a chemical-free sterilization method for ultra-pure water systems used in reagent prep.
Precision Dispensing Diamond Nozzles High-throughput screening involves millions of micro-dispensing cycles. Diamond-coated or solid diamond apertures resist wear and chemical erosion from aggressive solvents/antibiotics, ensuring long-term volumetric accuracy.

Engagement Hooks

  • Technical Question: "As you scale your AI-driven drug discovery and high-throughput screening, are you finding that electrode fouling in electrochemical sensing or thermal bottlenecks in your compute clusters are limiting your real-time data acquisition speeds?"
  • Value Statement: "6C can transform your biosensing accuracy and AI hardware reliability by leveraging the extreme thermal and electrochemical properties of CVD Diamond, ensuring your innate immunity research stays ahead of the hardware curve."